adambeyoncelowe
Senior Member (Voting Rights)
I wondered the same. If phenylalanine is being diverted to other uses then that might imply difficulty in producing its normal downstream products including dopamine, noradrenaline and adrenaline - which would imply some pretty systemic symptoms like we see in ME/CFS.
Xu et al do reference other studies that indicate a reduction in 'amino acids including phenylalanine' in blood and serum:
Now, this all needs to come with a pinch of salt given the fact Xu et al is a small pilot study, but - with that caveat applied - it does seem to give additional credence to a range of studies that indicate something is up with phenylalanine in at least a subset of patients. As with all metabolic studies, whether that is a cause of ME/CFS or caused by ME/CFS (i.e. does the fact that patients move less than healthy controls cause their metabolite pattern to differ?) is still to be seen. Additionally, this finding was with PBMCs and so we don't know if any metabolic shift is replicated in other tissues, which might indicate a primarily metabolic problem, or just PBMCs, which might indicate some form of immune system activation. Still, caveats aside, it is encouraging to see findings that seem to support each other - i.e. increase phenylalanine in cells = lowered elsewhere.
- Armstrong et al, 2012 - found reduced glutamine and orthinine. Phenylalanine was not significantly reduced (p=0.35) on an absolute basis. However, it was correlated with the overall (reduced) level of orthinine;
- Armstrong et al, 2015 - phenylalanine was decreased in ME/CFS patients (p=0.003)
- Fluge et al, 2016 - the famous pyruvate paper
- the only mention I can find of phenylalanine, using my highly scientific Ctrl+F approach, is a reference back to the 2015 Armstrong paper above. This paper did find lots of other reduced amino acids though
- Niblett et al 2007- lower excretion of phenylalanine in urine (p<0.003) alongside a number of other compounds. Also references an earlier study (Jones et al, 2005) that found that urinary excreta differed between CFS and depressed patients
This might also be why drugs like amitriptyline work for a minority of patients (it increases noradrenaline, as do the SNRIs used in FM).
So is this a good study, in general? Do we think this is an important finding?